A Case of Human Papillomavirus-positive Nasal Vestibule Squamous Cell Carcinoma
暂无分享,去创建一个
[1] J. Dahlstrom,et al. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV. , 2019, Pathology.
[2] J. Eloy,et al. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma , 2017, International forum of allergy & rhinology.
[3] O. Tawfik,et al. Outcomes of HPV‐related nasal squamous cell carcinoma , 2017, The Laryngoscope.
[4] J. Eloy,et al. Malignant Primary Neoplasms of the Nasal Cavity and Paranasal Sinus , 2016, Current Otorhinolaryngology Reports.
[5] R. de Bree,et al. The role of systemic therapy in the management of sinonasal cancer: A critical review. , 2015, Cancer treatment reviews.
[6] J. Ordi,et al. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas , 2014, Modern Pathology.
[7] J. Eloy,et al. Epidemiology of sinonasal squamous cell carcinoma: A comprehensive analysis of 4994 patients , 2014, The Laryngoscope.
[8] S. Syrjänen,et al. Detection of human papillomavirus in sinonasal carcinoma: systematic review and meta-analysis. , 2013, Human pathology.
[9] J. Turner,et al. Incidence and survival in patients with sinonasal cancer: A historical analysis of population‐based data , 2012, Head & neck.
[10] X. Castellsagué,et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review , 2012, BMC Cancer.
[11] M. Poljak,et al. Sinonasal inverted papilloma associated with squamous cell carcinoma , 2011, Radiology and oncology.
[12] C. Snyderman,et al. Contemporary management of sinonasal cancer , 2011, Head & neck.
[13] V. Vander Poorten,et al. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[14] M. Stanley. HPV - immune response to infection and vaccination , 2010, Infectious Agents and Cancer.
[15] W. Quint,et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome , 2009, Cancer.
[16] G. Costa,et al. A case-control study on occupational risk factors for sino-nasal cancer , 2009, Occupational and Environmental Medicine.
[17] W. Lawson,et al. The Role of the Human Papillomavirus in the Pathogenesis of Schneiderian Inverted Papillomas: An Analytic Overview of the Evidence , 2008, Head and neck pathology.
[18] A. Nulens,et al. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] Danielle W. Lu,et al. Prevalence of High-Risk Human Papillomavirus DNA in Nonkeratinizing (Cylindrical Cell) Carcinoma of the Sinonasal Tract: A Distinct Clinicopathologic and Molecular Disease Entity , 2005, The American journal of surgical pathology.
[20] Diane D. Liu,et al. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ‐preservation approach in patients with paranasal sinus carcinoma , 2003, Cancer.
[21] K. Syrjänen,et al. HPV infections in benign and malignant sinonasal lesions , 2003, Journal of clinical pathology.
[22] G. Mastrangelo,et al. Epidemiologic evidence of cancer risk in textile industry workers: a review and update , 2002, Toxicology and industrial health.
[23] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[24] R. Hayes,et al. Tobacco use and sinonasal cancer: a case-control study. , 1987, British Journal of Cancer.
[25] A. Weber,et al. Malignant tumors of the paranasal sinuses: radiologic, clinical, and histopathologic evaluation of 200 cases. , 1984, Head & neck surgery.